Monday, May 26, 2014
The top decile of private European money raisers
elevated their game in 2013, averaging $63.3 million vs. $49.7 million in 2012,
and better than matching the average of $62.3 million raised by the top 10% of
private biotechs in the U.S. last year. The average raised by top U.S. teams
also was down from $87.4 million in 2012.
Overall, private European biotechs that raised money
last year averaged $15 million, up from